Fabio
85 lines
5.0 KiB
Markdown
85 lines
5.0 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Drug Control Act; classifies gabapentin as a Schedule V controlled substance."
|
||
description: "Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2019"
|
||
identifier: "HB 2557"
|
||
citation: "Virginia HB 2557 (2019)"
|
||
classification: ["bill"]
|
||
subjects: ["Narcotics and Drugs", "Professions and Occupations"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Todd E. Pillion"]
|
||
version_count: 4
|
||
action_count: 19
|
||
vote_count: 6
|
||
first_action: "2019-01-09"
|
||
last_action: "2019-03-05"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/4b30923f-961a-471d-bbc1-a292b753b21e"
|
||
source_url: "http://lis.virginia.gov/cgi-bin/legp604.exe?191+sum+HB2557"
|
||
source_hash: "8a02e8b2be8eefe8854a92eb0a19922ec65f2bdcebd3e350ea76810195cf582a"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia HB 2557 (2019) — Drug Control Act; classifies gabapentin as a Schedule V controlled substance.
|
||
|
||
Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Governor: Acts of Assembly Chapter text (CHAP0214)** (committee substitute) — [source](http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+CHAP0214)
|
||
2. **House: Bill text as passed House and Senate (HB2557ER)** (committee substitute) — [source](http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+HB2557ER)
|
||
3. **House: Prefiled and ordered printed; offered 01/09/19 19101661D** (committee substitute) — [source](http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+HB2557)
|
||
4. **Senate: Committee substitute printed 19106567D-S1** (committee substitute) — [source](http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+HB2557S1)
|
||
|
||
## Votes
|
||
|
||
- Passed Senate with substitute — **40–0** (pass) · upper
|
||
- Senate substitute agreed to by House 19106567D-S1 — **97–0** (pass) · lower
|
||
- Reported from Health, Welfare and Institutions — **22–0** (pass) · lower
|
||
- Constitutional reading dispensed — **40–0** (pass) · upper
|
||
- Reported from Education and Health with substitute — **15–0** (pass) · upper
|
||
- Read third time and passed House BLOCK VOTE — **99–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Todd E. Pillion — primary (person)
|
||
- Israel D. O'Quinn — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2019-01-09** Prefiled and ordered printed; offered 01/09/19 19101661D `introduction`
|
||
- **2019-01-09** Referred to Committee on Health, Welfare and Institutions `referral-committee`
|
||
- **2019-01-24** Read first time `reading-1`
|
||
- **2019-01-25** Read second time and engrossed `reading-2`
|
||
- **2019-01-28** Read third time and passed House BLOCK VOTE (99-Y 0-N) `passage, reading-3`
|
||
- **2019-01-29** Constitutional reading dispensed
|
||
- **2019-01-29** Referred to Committee on Education and Health `referral-committee`
|
||
- **2019-02-11** Read third time `reading-3`
|
||
- **2019-02-11** Reading of substitute waived
|
||
- **2019-02-11** Committee substitute agreed to 19106567D-S1
|
||
- **2019-02-11** Engrossed by Senate - committee substitute HB2557S1
|
||
- **2019-02-13** Placed on Calendar
|
||
- **2019-02-13** Senate substitute agreed to by House 19106567D-S1 (97-Y 0-N)
|
||
- **2019-02-15** Enrolled
|
||
- **2019-02-15** Signed by Speaker
|
||
- **2019-02-15** Signed by President
|
||
- **2019-02-19** Enrolled Bill communicated to Governor on February 19, 2019
|
||
- **2019-02-19** Governor's Action Deadline Midnight, March 26, 2019
|
||
- **2019-03-05** Approved by Governor-Chapter 214 (effective 7/1/19) `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/4b30923f-961a-471d-bbc1-a292b753b21e`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|